Clinical Trial Update: Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating weekly vinorelbine in combination with oral capecitabine for stage IV breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Navelbine (vinorelbine)
• Xeloda (capecitabine)

Snippet

Sponsor: University of Washington | Conditions: Breast Neoplasm | Phase 2 | Status: COMPLETED